Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results on immunologic reconstitution in HIV-1 infected children receiving HAART with ritonavir, nevirapine, and stav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)
  • Ritonavir (Ritonavir)
  • stavudine (stavudine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED